Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Capital Employed (avg) of 13.34% signifying low profitability per unit of total capital (equity and debt)
2
Flat results in Dec 24
3
With ROE of 15.04%, it has a Very Expensive valuation with a 3.48 Price to Book Value
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.18%
0%
-15.18%
6 Months
-24.07%
0%
-24.07%
1 Year
-30.68%
0%
-30.68%
2 Years
-9.46%
0%
-9.46%
3 Years
16.93%
0%
16.93%
4 Years
-14.74%
0%
-14.74%
5 Years
13.14%
0%
13.14%
Siegfried Holding AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.35%
EBIT Growth (5y)
35.19%
EBIT to Interest (avg)
24.94
Debt to EBITDA (avg)
1.98
Net Debt to Equity (avg)
0.50
Sales to Capital Employed (avg)
0.95
Tax Ratio
18.53%
Dividend Payout Ratio
10.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.34%
ROE (avg)
16.24%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
3.48
EV to EBIT
21.23
EV to EBITDA
14.57
EV to Capital Employed
2.75
EV to Sales
3.08
PEG Ratio
NA
Dividend Yield
0.08%
ROCE (Latest)
12.94%
ROE (Latest)
15.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
1,271.50
1,229.50
3.42%
Operating Profit (PBDIT) excl Other Income
249.30
309.60
-19.48%
Interest
9.30
7.60
22.37%
Exceptional Items
0.00
0.00
Consolidate Net Profit
112.70
156.50
-27.99%
Operating Profit Margin (Excl OI)
132.00%
185.10%
-5.31%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 3.42% vs 11.53% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -27.99% vs 63.70% in Dec 2022
About Siegfried Holding AG 
Siegfried Holding AG
Pharmaceuticals & Biotechnology
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.
Company Coordinates 
Company Details
Untere Bruehlstrasse 4 , ZOFINGEN None : 4800
Registrar Details






